vs
Natera, Inc.（NTRA）与WEX Inc.（WEX）财务数据对比。点击上方公司名可切换其他公司
WEX Inc.的季度营收约是Natera, Inc.的1.0倍（$673.8M vs $665.5M），WEX Inc.净利率更高（11.5% vs 7.1%，领先4.4%），Natera, Inc.同比增速更快（39.8% vs 5.8%），WEX Inc.自由现金流更多（$49.5M vs $37.8M），过去两年Natera, Inc.的营收复合增速更高（34.5% vs 18.7%）
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
WEX Inc.是专注服务于美国商业及政府车队领域的支付处理与信息管理服务提供商，总部位于美国缅因州波特兰市，业务范围覆盖美国、加拿大、南美、欧洲、亚洲及澳大利亚等多个全球区域。
NTRA vs WEX — 直观对比
营收规模更大
WEX
是对方的1.0倍
$665.5M
营收增速更快
NTRA
高出33.9%
5.8%
净利率更高
WEX
高出4.4%
7.1%
自由现金流更多
WEX
多$11.7M
$37.8M
两年增速更快
NTRA
近两年复合增速
18.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $665.5M | $673.8M |
| 净利润 | $47.3M | $77.7M |
| 毛利率 | — | — |
| 营业利润率 | -3.4% | 23.5% |
| 净利率 | 7.1% | 11.5% |
| 营收同比 | 39.8% | 5.8% |
| 净利润同比 | 187.9% | 8.7% |
| 每股收益（稀释后） | $0.36 | $2.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NTRAWEX
| Q1 26 | — | $673.8M | ||
| Q4 25 | $665.5M | $465.1M | ||
| Q3 25 | $592.2M | $481.6M | ||
| Q2 25 | $546.6M | $454.4M | ||
| Q1 25 | $501.8M | $444.3M | ||
| Q4 24 | $476.1M | $440.3M | ||
| Q3 24 | $439.8M | $479.0M | ||
| Q2 24 | $413.4M | $478.6M |
净利润NTRAWEX
| Q1 26 | — | $77.7M | ||
| Q4 25 | $47.3M | $84.2M | ||
| Q3 25 | $-87.5M | $80.3M | ||
| Q2 25 | $-100.9M | $68.1M | ||
| Q1 25 | $-66.9M | $71.5M | ||
| Q4 24 | $-53.8M | $63.9M | ||
| Q3 24 | $-31.6M | $102.9M | ||
| Q2 24 | $-37.5M | $77.0M |
毛利率NTRAWEX
| Q1 26 | — | — | ||
| Q4 25 | — | 39.0% | ||
| Q3 25 | — | 43.0% | ||
| Q2 25 | — | 40.0% | ||
| Q1 25 | — | 39.2% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | — | 48.0% | ||
| Q2 24 | — | 44.9% |
营业利润率NTRAWEX
| Q1 26 | — | 23.5% | ||
| Q4 25 | -3.4% | 35.7% | ||
| Q3 25 | -16.5% | 38.1% | ||
| Q2 25 | -20.2% | 34.5% | ||
| Q1 25 | -15.8% | 35.4% | ||
| Q4 24 | -13.6% | 35.7% | ||
| Q3 24 | -8.9% | 41.0% | ||
| Q2 24 | -10.6% | 35.1% |
净利率NTRAWEX
| Q1 26 | — | 11.5% | ||
| Q4 25 | 7.1% | 18.1% | ||
| Q3 25 | -14.8% | 16.7% | ||
| Q2 25 | -18.5% | 15.0% | ||
| Q1 25 | -13.3% | 16.1% | ||
| Q4 24 | -11.3% | 14.5% | ||
| Q3 24 | -7.2% | 21.5% | ||
| Q2 24 | -9.1% | 16.1% |
每股收益（稀释后）NTRAWEX
| Q1 26 | — | $2.22 | ||
| Q4 25 | $0.36 | $2.38 | ||
| Q3 25 | $-0.64 | $2.30 | ||
| Q2 25 | $-0.74 | $1.98 | ||
| Q1 25 | $-0.50 | $1.81 | ||
| Q4 24 | $-0.41 | $1.60 | ||
| Q3 24 | $-0.26 | $2.52 | ||
| Q2 24 | $-0.30 | $1.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $633.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.7B | $1.3B |
| 总资产 | $2.4B | $15.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NTRAWEX
| Q1 26 | — | $633.5M | ||
| Q4 25 | — | $5.2B | ||
| Q3 25 | $1.0M | $4.9B | ||
| Q2 25 | $16.0M | $4.9B | ||
| Q1 25 | $17.8M | $4.4B | ||
| Q4 24 | $22.7M | $4.4B | ||
| Q3 24 | $29.5M | $4.3B | ||
| Q2 24 | $90.3M | $4.0B |
股东权益NTRAWEX
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.7B | $1.2B | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.2B | $978.7M | ||
| Q1 25 | $1.2B | $810.4M | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $878.5M | $1.7B | ||
| Q2 24 | $836.5M | $1.8B |
总资产NTRAWEX
| Q1 26 | — | $15.4B | ||
| Q4 25 | $2.4B | $14.4B | ||
| Q3 25 | $1.8B | $14.4B | ||
| Q2 25 | $1.8B | $14.7B | ||
| Q1 25 | $1.7B | $14.0B | ||
| Q4 24 | $1.7B | $13.3B | ||
| Q3 24 | $1.6B | $14.0B | ||
| Q2 24 | $1.5B | $14.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.9M | — |
| 自由现金流经营现金流 - 资本支出 | $37.8M | $49.5M |
| 自由现金流率自由现金流/营收 | 5.7% | 7.3% |
| 资本支出强度资本支出/营收 | 5.4% | 5.6% |
| 现金转化率经营现金流/净利润 | 1.56× | — |
| 过去12个月自由现金流最近4个季度 | $109.1M | $877.4M |
8季度趋势，按日历期对齐
经营现金流NTRAWEX
| Q1 26 | — | — | ||
| Q4 25 | $73.9M | $294.7M | ||
| Q3 25 | $59.4M | $376.6M | ||
| Q2 25 | $37.6M | $264.6M | ||
| Q1 25 | $44.5M | $-481.6M | ||
| Q4 24 | $52.9M | $638.4M | ||
| Q3 24 | $51.8M | $3.3M | ||
| Q2 24 | $4.0M | $-7.0M |
自由现金流NTRAWEX
| Q1 26 | — | $49.5M | ||
| Q4 25 | $37.8M | $256.3M | ||
| Q3 25 | $37.0M | $341.6M | ||
| Q2 25 | $11.7M | $230.0M | ||
| Q1 25 | $22.6M | $-514.2M | ||
| Q4 24 | $34.8M | $599.7M | ||
| Q3 24 | $35.5M | $-31.7M | ||
| Q2 24 | $-7.7M | $-46.6M |
自由现金流率NTRAWEX
| Q1 26 | — | 7.3% | ||
| Q4 25 | 5.7% | 55.1% | ||
| Q3 25 | 6.2% | 70.9% | ||
| Q2 25 | 2.1% | 50.6% | ||
| Q1 25 | 4.5% | -115.7% | ||
| Q4 24 | 7.3% | 136.2% | ||
| Q3 24 | 8.1% | -6.6% | ||
| Q2 24 | -1.9% | -9.7% |
资本支出强度NTRAWEX
| Q1 26 | — | 5.6% | ||
| Q4 25 | 5.4% | 8.3% | ||
| Q3 25 | 3.8% | 7.3% | ||
| Q2 25 | 4.7% | 7.6% | ||
| Q1 25 | 4.3% | 7.3% | ||
| Q4 24 | 3.8% | 8.8% | ||
| Q3 24 | 3.7% | 7.3% | ||
| Q2 24 | 2.8% | 8.3% |
现金转化率NTRAWEX
| Q1 26 | — | — | ||
| Q4 25 | 1.56× | 3.50× | ||
| Q3 25 | — | 4.69× | ||
| Q2 25 | — | 3.89× | ||
| Q1 25 | — | -6.74× | ||
| Q4 24 | — | 9.99× | ||
| Q3 24 | — | 0.03× | ||
| Q2 24 | — | -0.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTRA
暂无分部数据
WEX
| Payment processing revenue | $284.2M | 42% |
| Account servicing revenue | $182.5M | 27% |
| Other revenue | $127.0M | 19% |
| Finance fee revenue | $80.1M | 12% |
